CHINA PHARMA HOLDINGS, INC. Increase (Decrease) in Other Receivables
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Increase (Decrease) in Other Receivables of -$342.01 thousand for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2014-11-14
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in other receivables for the quarter ending 2013-09-30 was $16.01K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in other receivables for the quarter ending 2013-06-30 was -$294.75K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in other receivables for the quarter ending 2013-03-31 was -$173.76K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in other receivables for the quarter ending 2012-09-30 was -$47.07K, a 350.89% decline year-over-year.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month |
|---|---|---|---|
| 2014-09-30 | -$342.01K 10-Q · filed 2014-11-14 | ||
| 2013-09-30 | $16.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$278.74K derived: sum of 2 quarters · filed 2014-11-14 | -$452.50K 10-Q · filed 2014-11-14 |
| 2013-06-30 | -$294.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$468.51K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$173.76K 10-Q · filed 2013-05-14 | ||
| 2012-09-30 | -$47.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$53.33K derived: sum of 2 quarters · filed 2013-11-14 | -$73.58K 10-Q · filed 2013-11-14 |
| 2012-06-30 | -$6.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$26.50K 10-Q · filed 2013-08-14 | |
| 2012-03-31 | -$20.25K 10-Q · filed 2013-05-14 | ||
| 2011-09-30 | $18.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $76.16K derived: sum of 2 quarters · filed 2012-11-14 | $3.20K 10-Q · filed 2012-11-14 |
| 2011-06-30 | $57.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$15.56K 10-Q · filed 2012-08-14 | |
| 2011-03-31 | -$72.95K 10-Q · filed 2012-05-14 | ||
| 2010-09-30 | -$43.34K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-03-06 | -$69.15K 10-Q/A · filed 2012-03-06 | |
| 2010-06-30 | -$25.81K 10-Q/A · filed 2011-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |